What is Ava?
Ava is a specialized digital health enterprise headquartered in Zurich, with an expansive international footprint including offices in San Francisco, Belgrade, and Makati. The company is at the forefront of the femtech industry, utilizing artificial intelligence and rigorous clinical research to advance women's reproductive health. Its flagship product, a fertility tracking sensor bracelet, provides users with real-time insights into their reproductive cycles with 90% accuracy. By integrating sophisticated data analytics with wearable hardware, Ava offers a personalized approach to fertility management, positioning itself as a critical tool for individuals navigating reproductive health journeys.
How much funding has Ava raised?
Ava has raised a total of $42.3M across 3 funding rounds:
Angel/Seed
$2.6M
Series A
$9.7M
Series B
$30M
Angel/Seed (2015): $2.6M with participation from Swisscom and Zu00fcrcher Kantonalbank
Series A (2016): $9.7M led by Blue Ocean Ventures, Global Sources, Zurich Cantonal Bank, Polytech Ventures, and Swisscom
Series B (2018): $30M supported by Blue Ocean Ventures, Zurich Cantonal Bank, Global Sources, SVC Ltd., Swisscom, btov, and Polytech Ventures
Key Investors in Ava
Blue Ocean Ventures
BlueOcean Ventures is an investment company focused on early-stage medical device and life science companies, targeting untapped markets. They provide portfolio companies with a robust network of industry experts and strategic guidance.
Zurich Cantonal Bank
Zürcher Kantonalbank is a leading universal bank headquartered in Switzerland, offering a comprehensive range of financial products including business financing and capital market transactions.
Swisscom
Swisscom is a major Swiss telecommunications provider, majority-owned by the Swiss Confederation, providing essential infrastructure and digital services to individuals and businesses.
What's next for Ava?
Looking ahead, Ava is well-positioned to leverage its major enterprise-level funding to deepen its market penetration and expand its clinical research initiatives. The company's focus remains on refining its AI algorithms and potentially diversifying its product suite to address broader aspects of women's health. As the firm transitions into its next phase of maturity, the emphasis will likely shift toward scaling operations in key international markets and strengthening its partnerships with healthcare providers. This strategic roadmap is designed to maintain its competitive edge in the rapidly evolving digital health landscape while ensuring long-term sustainability and user engagement.
See full Ava company page
